Samjin Pharm (005500) — Cash Flow Quality Index
Samjin Pharm (005500) has a Cash Flow Quality Index of -0.21x as of September 2025. Operating cash flow of ₩-1.43 Billion is below net income of ₩6.84 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Samjin Pharm (005500) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Samjin Pharm Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Samjin Pharm across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Samjin Pharm to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Samjin Pharm (2013–2024)
Year-by-year earnings quality comparison for Samjin Pharm. For live market cap and the full company financial profile, see how much is Samjin Pharm worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.97x | ₩38.15 Billion | ₩39.23 Billion | ▲ +120.6% |
| 2023 | 0.44x | ₩8.33 Billion | ₩18.91 Billion | ▼ -44.2% |
| 2022 | 0.79x | ₩17.29 Billion | ₩21.89 Billion | ▼ -6.4% |
| 2021 | 0.84x | ₩23.97 Billion | ₩28.40 Billion | ▼ -1.4% |
| 2020 | 0.86x | ₩23.86 Billion | ₩27.88 Billion | ▼ -57.0% |
| 2019 | 1.99x | ₩23.63 Billion | ₩11.88 Billion | ▲ +68.8% |
| 2018 | 1.18x | ₩30.08 Billion | ₩25.53 Billion | ▲ +13.1% |
| 2017 | 1.04x | ₩37.28 Billion | ₩35.80 Billion | ▼ -35.4% |
| 2016 | 1.61x | ₩48.66 Billion | ₩30.17 Billion | ▲ +130.3% |
| 2015 | 0.70x | ₩18.94 Billion | ₩27.04 Billion | ▼ -55.2% |
| 2014 | 1.56x | ₩32.41 Billion | ₩20.72 Billion | ▲ +67.1% |
| 2013 | 0.94x | ₩7.37 Billion | ₩7.88 Billion | — |